- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- May 2025
- 180 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 191 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 196 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 195 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 188 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 182 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 185 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- August 2024
- 142 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- April 2025
- 320 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- March 2025
- 120 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 114 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 182 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 193 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- December 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- October 2024
- 88 Pages
Latin America
From €3090EUR$3,450USD£2,634GBP
- Report
- June 2025
United States
From €2553EUR$2,850USD£2,176GBP

The Tumor Marker market is a segment of the In Vitro Diagnostics (IVD) industry. It is composed of products used to detect the presence of cancer in a patient. These products are typically used to diagnose, monitor, and assess the effectiveness of cancer treatments. Tumor markers are typically proteins, hormones, or other substances that are produced by cancer cells or by the body in response to cancer. They can be detected in the blood, urine, or other body fluids.
The Tumor Marker market is a rapidly growing segment of the IVD industry, driven by the increasing prevalence of cancer and the need for early diagnosis and effective treatment. The market is expected to continue to grow in the coming years, driven by technological advancements and the development of new products.
Some of the major companies in the Tumor Marker market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more